The purpose of the study is to evaluate the effect of food on the pharmacokinetics of AZD0328 in healthy male volunteers. AZD0328 will be administered as a single oral dose (capsule) during two treatment periods, after food intake or during fasting condition.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
14
Oral capsule, single dose
Research Site
Lund, Sweden
PK variables
Time frame: Several PK samples during the study days
Safety variables (adverse events, blood pressure, laboratory measurements and paper ECGs)
Time frame: During the whole treatment period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.